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Abstract
Motivation: The recent outbreak of Ebola virus disease (EVD) resulted in a large number of human
deaths. Due to this devastation, the Ebola virus has attracted renewed interest as model for virus
evolution. Recent literature on Ebola virus (EBOV) has contributed substantially to our understand-
ing of the underlying genetics and its scope with reference to the 2014 outbreak. But no study yet,
has focused on the conservation patterns of EBOV proteins.
Results: We analyzed the evolution of functional regions of EBOV and highlight the function of con-
served residues in protein activities. We apply an array of computational tools to dissect the func-
tions of EBOV proteins in detail: (i) protein sequence conservation, (ii) protein–protein interactome
analysis, (iii) structural modeling and (iv) kinase prediction. Our results suggest the presence of novel
post-translational modifications in EBOV proteins and their role in the modulation of protein func-
tions and protein interactions. Moreover, on the basis of the presence of ATM recognition motifs in
all EBOV proteins we postulate a role of DNA damage response pathways and ATM kinase in EVD.
The ATM kinase is put forward, for further evaluation, as novel potential therapeutic target.
Availability and Implementation: http://www.biw.kuleuven.be/CSB/EBOV-PTMs
Contact: vera.vannoort@biw.kuleuven.be
Supplementary information: Supplementary data are available at Bioinformatics online.
1 Introduction
Ebola Virus (EBOV) is a virus in the family of Filoviridae and causes
severe hemorrhagic fever known as Ebola Virus Disease (EVD) with a
mortality rate of up to 90%. EBOV is a rather small pathogen with
only seven genes. The recent outbreak with epicenter in Guinea has
sparked a number of new genomics studies (Gire et al., 2014) that
showed the virus proteins are not undergoing rapid evolution (Hoenen
et al., 2015) and mutations in different EBOV proteins are correlated
with lethality (Deng et al., 2015). These studies did not address highly
conserved parts of proteins that we think may provide structural and
functional insight into molecular functions of EBOV proteins.
There is no suitable medicine commercially available to date for
EVD. Protein vaccines have failed to produce desired results in
human subjects (Ponomarenko et al., 2014). Recently, host calcium
channels were shown to be involved in virus host-cell entry (Sakurai
et al., 2015) and were put forward as novel drug target. Host kin-
ases also play a role in EVD, such as the PI3K kinase and PI3K/Akt
pathways in EBOV proliferation (Saeed et al., 2008). The inter-
action of ABL1 kinase with matrix protein VP40 has been linked to
EBOV endocytosis (Garcia et al., 2012). This association might fa-
cilitate morphogenesis and budding of new virions.
Different pathways and signaling cascades are routinely em-
ployed by viruses for infectivity (Lilley et al., 2007). An example is
the manipulation of Ras/MAPK pathways via IFN response that is
associated with the elevation of EBOV infection in mice (Strong
et al., 2008). The activation of Mitogen associated protein kinase
(MAPK) pathways like p38 pathway including DNA damage re-
sponse are dependent on ATM (Munshi and Ramesh, 2013).
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In order to gain more insight into the molecular biology of
EVD we here aim to identify evolutionary conserved residues and
assign functions to them. We do this by (i) collecting known and
predicting novel post-translational modifications on EBOV pro-
teins, (ii) mapping conserved residues on to three-dimensional
structures, (iii) collect protein–protein interactions between virus
and host proteins, (iv) find motifs that may mediate protein–
protein interactions and (v) map conserved and modified residues
to interaction interfaces.
2 Methods
We calculated residue level conservation for each Ebola protein
based on 520 unique EBOV genomes. We annotated these with
Post-translational Modifications and motifs and mapped them
to known and modeled 3D-structures. For more details see
Supplementary Methods.
3 Results
To identify important functions of individual residues in EBOV pro-
teins, we combined residue conservation with several computational
predictions and existing data.
3.1 Molecular functions of conserved residues
We created multiple sequences alignments for all EBOV proteins
based on whole genome sequencing data of 520 EBOV genomes and
identified highly conserved regions. Next, we annotated molecular
functions to those conserved regions. Post-translational modifica-
tions (PTMs) are known for their role in protein activities and it has
been shown that modified residues are more conserved than unmodi-
fied residues (Minguez et al., 2012). We collected published data on
modified residues in Ebola proteins. Only few PTMs have been char-
acterized so far including thirteen phosphorylation sites; thus we ex-
tended the PTM repertoire by predicting novel posttranslational
modifications. As EBOV proteins reside in the human host cell, we
assume human modifying enzymes can modify them. We employed
widely used neural network and SVM based published prediction
methods trained on human PTM data to predict modified residues
on EBOV proteins. We validated this strategy against published
phosphorylation data; the prediction methods were able to predict
eight out of thirteen published phosphorylation sites in EBOV
(Supplementary Table S1). For further analyses we included modi-
fied residues in our final repertoire that had highest prediction value
and all previously published PTMs.
The new list of PTMs is composed of 10 different types and 88
conserved PTM carrying amino acid residues in seven EBOV pro-
teins (Fig. 1, Supplementary Table S2). Among predicted PTMs in
EBOV proteins, phosphorylation is the most prevalent PTM type
with 42 sites followed by methylation and o-glycosylation. Some of
the PTMs are present in functional domains of EBOV proteins
(Supplementary Table S2). Modified residues present at protein
interaction interfaces may be important to virus proteins as immune
escape is achieved through interaction with different host proteins
(Fig. 2). The presence of different PTM-types on EBOV proteins like
methylation and phosphorylation in glycoprotein (GP) can explain
previously missing multiplicity of EBOV protein functions and regu-
lation. Although previously, no specific role could be found for GP
lipidation (Ito et al., 2001), the conservation level suggests a crucial
role, potentially in binding GP to lipid rafts together with the newly
predicted conserved GPI-anchor site. The conserved SUMOylated
residues in L-Protein could be responsible for nuclear localization
for this protein.
Interestingly, for some of the modification types no sites were
predicted at all, for example we did not predict any ubiquitination
site for any of EBOV proteins. The simple explanation for that may
be that virus proteins may avoid degradation and thus lack se-
quences that resemble ubiquitination signals.
3.2 Conserved residues in 3D structures
We map conservation from multiple sequence alignments of EBOV
proteins to their protein tertiary structures (Celniker et al., 2013).
The tertiary structures of proteins were retrieved from PDB (Berman
et al., 2000). Only VP24 has a completely resolved protein structure
whereas other EBOV proteins have partial structures either alone or
in complex with other proteins in PDB (except for L protein). In
order to evaluate the conservation of complete proteins in different
structural domains, we extended our analyses to model complete
EBOV proteins. We used a knowledge-based computational method
to predict and refine the finished protein structures (Yang et al.,
2014; Zhang 2009; details see Supplementary Methods). EBOV pro-
teins contain a variety of domains of which some are completely
conserved and others are completely variable (Fig. 1, Supplementary
Fig. S1). For example in Glycoprotein the unstructured regions have
very low sequence conservation, whereas the helical parts are highly
conserved. We annotate the known and predicted PTMs to con-
served residues. This results in 14 modified residues present in
known EBOV protein structures (Supplementary Table S3) and 88 if
modeled structures are included (Supplementary Table S2).
3.3 Short motifs predict interactions with host proteins
Another approach to obtain mechanistic insight into the virus protein
functions is based on finding short linear motifs. We employ Gibbs
sampling (Davey et al., 2010) and identify [ST]N.L.[FIV] known as
Dok1 PTB domain binding motif in all EBOV proteins except for
VP30 and twice in VP40. Dok proteins are adaptor molecules known
for their role in regulation of signal transduction (Zhang et al., 2004).
Conserved PTB domains are found in many proteins and implicated
for protein–protein interactions (Zhang et al., 2004). Dok1 protein is
known to bind through its PTB domain with protein kinases including
Abelson tyrosine kinase (ABL1) (Cong et al., 1999). ATM activates
ABL1 (Shafman et al., 1997) and ABL1 kinase phosphorylates many
targets to facilitate cellular responses like intracellular mobility and
M
M
GPI
GPI P
M
M
O O
BA
P
Fig. 1. Ebola Glycoprotein (GP) conservation with post transitionally modified
residues at conserved regions. PTMs present in regions of glycoprotein, con-
servation level indicated by dark blue, most variable residues; dark red, fully
conserved sites; white, average conservation. Image created with ConSurf
(Celniker et al., 2013); (A) space filled and (B) backbone representation.
(Abbreviation: P¼phosphorylation, GPI¼GPI-anchor, O¼o-linked glycosyla-
tion, M¼Methylation)
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host cell exit. Recently ABL1 was shown to phosphorylate the EBOV
VP40 (Garcia et al., 2012) needed for the proliferation of new virus
particles during the EVD. The Dok1 PTB binding motif may be cru-
cial for this phosphorylation.
A second motif NPG.C was only found in VP30, VP35 and L
protein. This motif is called phosphotyrosine independent PTB do-
main motif and binds Dab-like PTB domains and functionally takes
part in signaling pathways like endocytosis.
3.4 Modified residues at protein interaction interfaces
EBOV proteins interact with other virus proteins for spreading and
with human proteins to evade host immunity or human proteins inter-
act with EBOV proteins to accomplish immunity. To inspect the major
interactions of EBOV proteins with host proteins or other virus pro-
teins, we reconstructed the EBOV protein interactome based on litera-
ture review (Fig. 2, Supplementary Table S4). We hypothesize that the
residues present at the interface should be more conserved and play
a functional role in protein–protein interactions. We identified con-
served residues with annotated PTMs in protein interaction interfaces
of known virus-host and virus-virus protein complexes from PDB
(Table 1). Three modified sites for glycoprotein are present in the inter-
face with neutralizing antibody, one such site in the interface between
NP-VP35, one modified residue at the interface of complex with
VP40-Nedd4, one modified residue between VP24 and KPNA1 and
one phosphosite in the same interface motif of two different 3D struc-
tures of the VP35 inhibitory domain with dsRNA (Supplementary
Table S1). The presence of these predicted modifications at conserved
residues of interface of a complex between two proteins suggest an im-
portant role of PTMs in EBOV protein complex formation.
3.5 ATMkinase central for EBOV functions
We analyzed which kinases could be involved in the phosphorylation
events of EBOV using published SVM based methods (Wong et al.,
2007). We identify three potential human kinases, including ATM
(ataxia telangiectasia mutated), GSK3 (glycogen synthase 3 kinase)
and CK2 (casein kinase 2). The ATM kinase could be linked to the
modification of the majority of phosphorylation sites (Table 2). The
ATM kinase is a major regulator of signaling pathways like DNA
damage response (DDR) pathway (Supplementary Tables S6, S7) and
interacts with other important kinases and transcription factors such
as ABL1, ATR, AKT1, PI3K, p53 and MDM2 (van der Lee et al.,
2014; Shafman et al., 1997; Shiloh and Ziv, 2013) (Fig. 3). ABL1 is a
master regulator during the cytoplasmic mobility and ABL1 itself is
Fig. 2. Ebola protein interactome. (A) The protein complex between VP35IID
(brown) and dsRNA (green) (PDBid: 3L26); red residues are modified sites
present in interface. (B) The protein complex between NP (brown)-VP35
(green) (PDBid: 4YPI), the PTM site present at interface shown in red. (C) The
major interactions of EBOV proteins; left virus-virus, right host-virus. These
interactions result in a number of different processes that either induce or
suppress the host immune response. That is, some interactions are beneficial
for the host whereas others are beneficial for the virus. The processes are
grouped in boxes for each EBOV protein. Box1 shows the first step of attach-
ment and entry of glycoprotein to host, boxes 2 and 3 are the interactive path-
ways to suppress the host immunity by vp35 and vp24, respectively, by
interacting with host immune proteins like IRF7 (known for its role in inter-
feron immunity); which may lead to the virus genome replication and tran-
scription. 4, host NEDD4 play a possible role in virus budding and
proliferation by interacting with and facilitating vp40 functions inside the host
Table 1. Post-translational modifications in protein interactions
Complex PDB ID PTM residues Interface residue/motif
GP with antibody 3VE0 40 40
GP with antibody 3VE0 543 543
GP with antibody 3VE0 588 588
VP35 with Np 4PYI 30 30
VP40 with Nedd4 2KQ0 119 119
VP35 with dsRNA 4LG2 272 271 (motif)
VP35IID with dsRNA 4U2X 272 271 (motif)
VP24 with KPNA1 3L26 138 138
Modified residues overlap with residues in interaction interfaces in experi-
mentally resolved 3D structures. Modified residue 272 of VP35 is next to the
residue 271 that is part of an interaction interface.
Fig. 3. The role of ATM kinase in EVD related signaling pathways. Red arrows
indicate novel interactions predicted in our analyses. Other arrows are
derived from literature 1. (Xiaofei and Kowalik, 2014) 2. (Munshi and Ramesh,
2013) 3. (Svegliati et al., 2014) 4. (Garcia et al., 2012) 5. (Shafman et al., 1997)
6. (Shiloh and Ziv, 2013) 7. (Saeed et al., 2008)
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phosphorylated by ATM kinase. Tyrosine phosphorylation of VP40
has been shown to be essential for Virion egress (Fig. 3, Garcia et al.,
2012). The p53 and MDM2 are integral part of apoptosis, cell cycle
and PI3K/Akt signaling pathways. EBOV uses PI3K signaling for cel-
lular entry (Saeed et al., 2008). Finally, ATM has been shown to regu-
late wnt signaling (Svegliati et al., 2014), both CK2 and GSK-3 are
part of the wnt signaling pathway (Seldin et al., 2005). Many viruses
exploit DDR pathways for their own survival inside the host
(reviewed elsewhere (Lilley et al., 2007). Based on the presence of
ATM Kinase motifs in EBOV proteins, we now suggest the activation
of DDR pathways by EBOV as well (Fig. 3).
In this study we have identified highly conserved residues in
EBOV proteins and explored their functional attributes by analysis
of post-translational modifications, protein–protein interactions and
linear motifs. The link with ATM Kinase motifs suggests the activa-
tion of DDR pathways in the presence of EBOV may trigger the pos-
sible ATM dependent phosphorylation cascades. Together these
data suggest the potential of ATM as an interesting therapeutic tar-
get to be explored in the context of EVD.
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